Introduction/Purpose: Insomnia is a sleep problem affecting many adults; especially, those with mental health issues (Roth, 2019). Insomnia has been linked to both physical and mental health issues. Providers in the clinical site for this project prescribe medications to manage insomnia. These medications have side effects that present safety risks to patients (Rossman, 2019). Cognitive Behavior Therapy for Insomnia (CBTI) has been recommended as the first-line evidence-based treatment for insomnia (Rossman, 2019). However, providers are not prescribing CBTI as a first-line treatment in the clinical site for this project. There was a knowledge deficit and lack of attitude related to the prescription of CBTI among the providers of the project site, as indicated by the surveys taken by these health providers. Therefore, we have conducted a quality improvement project to educate the health providers of this outpatient psychiatric clinic about the use of CBTI as the first-line treatment for insomnia in their adult patients who have insomnia.

Methods Design: This is a quality improvement project with a pretest-post-test design. We developed an evidence-based educational PowerPoint program for the providers. We adopted the evidence-based guidelines for the treatment of insomnia from AASM (American Academy of Sleep Medicine, 2023). We recruited all the providers from the facility (N=5). INCREASING PROVIDER KNOWLEDGE 4 Data Collection Tools: We used the Evidence-Based Attitude Scale (Aarons, 2004) to Assess their attitude regarding the prescription of CBTI for the treatment of insomnia among adults. The data was collected before (T0) and after the delivery of the intervention (T1). Intervention: An educational PowerPoint video (30 min) was delivered to the participants. The content materials included the benefits of using the CBTI, the side effects of medications used for the treatment of Insomnia, and the ladder of the different treatment regimens recommended for insomnia. Data analysis: Descriptive analyses were used to analyze the data. The mean and S.D. were computed on the data from the pre-and post-surveys to see any changes in the knowledge and attitude of providers toward prescribing CBT-I as the first-line treatment from the pre-test to post-test phase of the study.

Results: Our results showed changes in the provider's attitudes from the pre- to post-intervention phase regarding the prescription of CBTI as a first-line treatment for insomnia among adults. The providers expressed openness to trying new therapies/interventions.

Discussion: Our result indicated that the educational program improved the attitude of providers toward prescribing CBTI among adults for the treatment of insomnia. This project could be conducted on a large scale in the future.